Skip to main content
. 2024 Nov 15;41(Suppl 5):S1–S5. doi: 10.12788/fp.0525

TABLE 1.

Baseline Characteristics (N = 150)

Characteristic Results
Age, mean (SD), y 69.5 (9.7)

Sex, No. (%)
 Male 142 (94.7)
 Female 8 (5.3)

Race, White, No. (%) 134 (89.3)

Medications, No. (%)
 Insulin 150 (100)
 Sodium-glucose cotransporter 2-inhibitors 28 (18.7)
 Glucagon-like peptide-1 inhibitors 17 (11.3)
 Biguanides 70 (46.7)
 Dipeptidyl peptidase-4 inhibitors 11 (7.3)
 Thiazolidinediones 6 (4.0)
 Sulfonylureas 4 (2.7)